SHANGHAI, April 9, 2014 /PRNewswire/ -- In China NPC & CPPCC 2014, encouragement of transportation for pharmacy from API manufacturers to formulation manufacturers, formulation export, speed up new drug application and reform of basic drug bidding have become hot topics again.
(Photo: http://photos.prnasia.com/prnh/20140409/0861402219-a )
(Photo: http://photos.prnasia.com/prnh/20140409/0861402219-b )
Due to the success from 2 years of Pharma QbD, 4 years of Pharma Supply Chain, 4 years of Pharma Cold Chain and 4 years of NDDS organized by UBM, CPhI Conference will do the portfolio management of these pharmaceutical events to provide Global Pharma Congress 2014 during May 28-29, 2014 in InterContinental Shanghai Pudong, China. The three hot topics will be included in it and this event will make connection of different departments/functions of drug manufacturer. It is a good opportunity to accelerate communication of pharmaceutical industry and promote industry interaction.
Agenda At-A-Glance
Joint Plenary |
|
Day One Morning (Morning of May 28)
|
-- Global pharmaceutical development and the requirement for innovation and quality improvement |
Tracks |
|
Day One Afternoon + Day Two (Afternoon of May 28 + May 29)
|
Pharma QbD |
Pharma Cold Chain |
|
Formulation Development & NDDS |
These hot topics will be presented
- Action and prospects from regulator: Updates of Three-years Test Plan of QbD from FDA and EMA
- Advocacy and requirement QbD from FDA, how to use QbD to save cost and improve efficiency for manufacturers?
- QbD application in APIs with guideline of ICH-Q11, updates of DMF making, synthesis process determining and process analysis
- Impacts of new GSP on pharma cold chain: storage temperature & humidity detection and new requirement of distribution & transportation
- Application of temperature control to reduce drug consumption and ensure product quality
- Build pharma logistics system and to integrate service platform from perspectives of IT & network technology and temperature layer distribution solutions
- Innovation of formulation: from the perspectives of design idea, R&D and market access
- Dissolution test and bioequivalence test to improve formulation quality
- Project approval of formulation innovation and key technology of dosage design
Also the conference committee call for Speakers/Advisor Board
UBM is compiling a great roster of thought leaders and industry insiders for a program packed with timely insights, strategic views, and actionable items. If you would like the opportunity to speak at Global Pharma Congress or participate into advisor board, please submit your proposed topic, biography and contact information to conference producer:
Jessie Jiang (jessie.jiang@ubm.com / +86 21 6157 3933)
Visit the website learn more information www.pharm-congress.com
Contact us
Heron. Zhuang
+86-21-6157-3928
Julia. Zhu
+86-21-6157-3922
Share this article